{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:29:35Z","timestamp":1767706175621,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2017R1D1A1B03028108"],"award-info":[{"award-number":["2017R1D1A1B03028108"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejphar.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T02:09:24Z","timestamp":1554430164000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effects of cariprazine on hERG 1A and hERG 1A\/3.1 potassium channels"],"prefix":"10.1016","volume":"854","author":[{"given":"Hong Joon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bok Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang June","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.04.006_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1176\/appi.ajp.2012.11081214","article-title":"Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophrenia","volume":"169","author":"Apud","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.04.006_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/TCRM.S35137","article-title":"A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia","volume":"9","author":"Caccia","year":"2013","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ejphar.2019.04.006_bib3","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1038\/srep19976","article-title":"Schizophrenia-associated hERG channel Kv11.1-3.1 exhibits a unique trafficking deficit that is rescued through proteasome inhibition for high throughput screening","volume":"6","author":"Calcaterra","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2019.04.006_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00210-013-0911-y","article-title":"Escitalopram block of hERG potassium channels","volume":"387","author":"Chae","year":"2014","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/17425255.2013.759211","article-title":"Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability","volume":"9","author":"Citrome","year":"2013","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/eurheartj\/ehi092","article-title":"Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death","volume":"26","author":"De Bruin","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2019.04.006_bib7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1042\/BST0351060","article-title":"hERG channel trafficking: novel targets in drug-induced long QT syndrome","volume":"35","author":"Dennis","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2019.04.006_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-016-4450-3","article-title":"Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study","volume":"234","author":"Durgam","year":"2017","journal-title":"Psychopharmacology (Berlin)"},{"year":"2017","series-title":"Assessment Report. Reagila","author":"European Medicines Agency","key":"10.1016\/j.ejphar.2019.04.006_bib9"},{"key":"10.1016\/j.ejphar.2019.04.006_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2004.07.019","article-title":"Acquired QT interval prolongation and HERG: implications for drug discovery and development","volume":"500","author":"Finlayson","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib11","doi-asserted-by":"crossref","first-page":"C701","DOI":"10.1152\/ajpcell.00633.2008","article-title":"State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy","volume":"296","author":"Ganapathi","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-2236(96)10064-3","article-title":"Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs","volume":"20","author":"Grace","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2019.04.006_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2008.05.009","article-title":"The hERG potassium channel and hERG screening for drug-induced torsades de pointes","volume":"119","author":"Hancox","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.04.006_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045624","article-title":"The schizophrenia-associated Kv11.1-3.1 isoform results in reduced current accumulation during repetitive brief depolarizations","volume":"7","author":"Heide","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.04.006_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.ajp.2015.14050653","article-title":"Differential response to risperidone in schizophrenia patients by KCNH2 genotype and drug metabolizer status","volume":"173","author":"Heide","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.04.006_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm.1962","article-title":"A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia","volume":"15","author":"Huffaker","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.04.006_bib17","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.1074\/jbc.M113.531277","article-title":"Role of the cytoplasmic N-terminal Cap and Per-Arnt-Sim (PAS) domain in trafficking and stabilization of Kv11.1 channels","volume":"289","author":"Ke","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.04.006_bib18","first-page":"H199","article-title":"Pathways of HERG inactivation","volume":"277","author":"Kiehn","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00210-017-1364-5","article-title":"Inhibition of cloned hERG potassium channels by risperidone and paliperidone","volume":"390","author":"Lee","year":"2017","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib20","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher","year":"2004","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.04.006_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjp.0704784","article-title":"Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine","volume":"136","author":"Paul","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib22","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1113\/jphysiol.2008.155762","article-title":"ERG voltage-gated K+ channels regulate excitability and discharge dynamics of the medial vestibular nucleus neurones","volume":"586","author":"Pessia","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bjp.0706892","article-title":"Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine","volume":"149","author":"Rajamani","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib24","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1152\/jn.00104.2003","article-title":"Functional roles of an ERG current isolated in cerebellar Purkinje neurons","volume":"90","author":"Sacco","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.04.006_bib26","first-page":"49","article-title":"Cariprazine for schizophrenia and bipolar disorder","volume":"13","author":"Scarff","year":"2016","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2019.04.006_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14740338.7.2.181","article-title":"Sudden cardiac death secondary to antidepressant and antipsychotic drugs","volume":"7","author":"Sicouri","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2019.04.006_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/sj.bjp.0707356","article-title":"State dependent dissociation of HERG channel inhibitors","volume":"151","author":"Stork","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.006_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.300.2.543","article-title":"The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels","volume":"300","author":"Thomas","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.04.006_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3565(25)24304-X","article-title":"Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes","volume":"272","author":"Wang","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.04.006_bib31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1126\/science.6136093","article-title":"Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons","volume":"221","author":"White","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.04.006_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00424-002-0936-4","article-title":"Biophysical properties of heteromultimeric erg K+ channels","volume":"445","author":"Wimmers","year":"2002","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2019.04.006_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s004240000467","article-title":"Erg1, erg2 and erg3 K channel subunits are able to form heteromultimers","volume":"441","author":"Wimmers","year":"2001","journal-title":"Pfl\u00fcgers Archiv"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919302341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919302341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:26:45Z","timestamp":1757975205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919302341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"alternative-id":["S0014299919302341"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.04.006","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of cariprazine on hERG 1A and hERG 1A\/3.1 potassium channels","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}